par
Astrid Fiano, DOTmed News Writer | September 16, 2009
--An excise tax of 35 percent on insurance companies and plan administrators for any plan above the threshold of $8,000 for singles and $21,000 for family plans.
--An annual flat fee of $2.3 billion for pharmaceutical manufacturers allocated according to market share except for those companies with sales of $5 million or less.
Ad Statistics
Times Displayed: 2016
Times Visited: 21 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
--An annual flat fee of $4 billion for medical device manufacturers allocated according to market share and also not applicable to companies with sales of $5 million or less.
--An annual flat fee of $6 billion for health insurance companies allocated according to market share.
--An annual flat fee of $750 million on clinical laboratories allocated according to market share.
The complete Chairman's Mark may be accessed at: http://finance.senate.gov/sitepages/leg/LEG%202009/091609%20Americas_Healthy_Future_Act.pdf
Senator's Baucus' comments may be accessed at: http://finance.senate.gov/press/Bpress/2009press/prb091609.pdf
Read AdvaMed's statement by clicking on DOTmed's Press Room.
Back to HCB News
